Direxion Daily S&P Biotech Bear 3X ETF
LABD
17 hedge funds and large institutions have $14.6M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 8 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
167% more call options, than puts
Call options by funds: $27M | Put options by funds: $10.1M
14.19% more ownership
Funds ownership: 2.74% → 16.94% (+14%)
6% less funds holding
Funds holding: 18 → 17 (-1)
12% less capital invested
Capital invested by funds: $16.6M → $14.6M (-$1.98M)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JF
Jump Financial
Chicago,
Illinois
|
+$3.82M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.68M |
| 3 |
GS
GTS Securities
New York
|
+$1.15M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.04M |
| 5 |
TSS
Two Sigma Securities
New York
|
+$590K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
-$1.39M |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$893K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$697K |
| 4 |
VF
Virtu Financial
New York
|
-$640K |
| 5 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$290K |
LABD Hedge Fund Activity: Q4 2025 in Review
17 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q4 2025, worth a combined $14.6M — down 12% from $16.6M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of LABD and 7 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 8 added.
The largest buyer was Jump Financial, opening a new position worth an estimated $3.82M. The largest seller was Ikarian Capital, cutting an estimated $1.39M.
- 17 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q4 2025, down from 18 in Q3 2025.
- Funds reported $14.6M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q4 2025, down 12% quarter-over-quarter.
- 7 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q4 2025 and 8 closed out, a net change of -1 holder.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q4 2025 was Jump Financial, an estimated $3.82M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q4 2025 was Ikarian Capital, an estimated $1.39M sold.
Based on aggregated 13F filings for Q4 2025.